68 related articles for article (PubMed ID: 3984061)
1. [Omeprazole treatment in the Zollinger-Ellison syndrome].
Bardram L; Stage JG; Stadil F
Ugeskr Laeger; 1985 Mar; 147(10):867-9. PubMed ID: 3984061
[No Abstract] [Full Text] [Related]
2. Omeprazole in the Zollinger-Ellison syndrome.
Bardram L; Stadil F
Scand J Gastroenterol; 1986 Apr; 21(3):374-8. PubMed ID: 3715402
[TBL] [Abstract][Full Text] [Related]
3. Control of acute Zollinger-Ellison syndrome with intravenous omeprazole.
Blanchi A; Delchier JC; Soule JC; Payen D; Bader JP
Lancet; 1982 Nov; 2(8309):1223-4. PubMed ID: 6128530
[No Abstract] [Full Text] [Related]
4. Reduction of gastric hypersecretion in Zollinger-Ellison syndrome with omeprazole.
Oberg K; Lindström H
Lancet; 1983 Jan; 1(8314-5):66-7. PubMed ID: 6129395
[No Abstract] [Full Text] [Related]
5. Treatment of patients with Zollinger-Ellison syndrome.
Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome.
McArthur KE; Collen MJ; Maton PN; Cherner JA; Howard JM; Ciarleglio CA; Cornelius MJ; Jensen RT; Gardner JD
Gastroenterology; 1985 Apr; 88(4):939-44. PubMed ID: 3972233
[TBL] [Abstract][Full Text] [Related]
7. [Omeprazole, the drug of the future for the treatment of Zollinger-Ellison syndrome and duodenal ulcer?].
Fiasse R; Tomé G; Dive C
Acta Gastroenterol Belg; 1984; 47(6):555-68. PubMed ID: 6537111
[No Abstract] [Full Text] [Related]
8. [Substituted benzimidazoles--a new dimension in ulcer therapy?].
Fimmel CJ; Blum AL
Wien Klin Wochenschr; 1984 Feb; 96(4):149-53. PubMed ID: 6324498
[TBL] [Abstract][Full Text] [Related]
9. [Omeprazole and inhibition of gastric acid secretion].
Rossi G
Recenti Prog Med; 1984 Apr; 75(4):419-21. PubMed ID: 6729204
[No Abstract] [Full Text] [Related]
10. Omeprazole: a comprehensive review.
Massoomi F; Savage J; Destache CJ
Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
[TBL] [Abstract][Full Text] [Related]
11. The medical management of Zollinger-Ellison syndrome.
Rhodes JM
Q J Med; 1991 Mar; 78(287):191-3. PubMed ID: 1675470
[No Abstract] [Full Text] [Related]
12. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
Mignon M; Hochlaf S; Forestier S; Ruszniewski P; Vatier J; Joubert-Collin M
Gastroenterol Clin Biol; 1994; 18(1):13-6. PubMed ID: 8187984
[TBL] [Abstract][Full Text] [Related]
13. Gastric carcinoid tumours in patients with Zollinger-Ellison syndrome on long-term omeprazole.
Goldfain D; le Bodic MF; Lavergne A; Galian A; Modigliani R
Lancet; 1989 Apr; 1(8641):776-7. PubMed ID: 2564577
[No Abstract] [Full Text] [Related]
14. [Stenosing esophagitis in Zollinger-Ellison syndrome].
Cadiot G; Hélie C; Vallot T; Marmuse JP; Cosnes J; Riché A; Mignon M
Gastroenterol Clin Biol; 1994; 18(11):1018-20. PubMed ID: 7705560
[TBL] [Abstract][Full Text] [Related]
15. The SSAT-AGA (Society for Surgery of the Alimentary Tract-American Gastroenterological Association). New Orleans, May 20-23, 1984.
Ashley SW; Cheung LY
Surg Gastroenterol; 1984; 3(2):47-53. PubMed ID: 6443718
[No Abstract] [Full Text] [Related]
16. [Zollinger-Ellison syndrome: long-term treatment with ranitidine].
Mony M; Lavoie S; Lemire S
Union Med Can; 1986 Mar; 115(3):149-50. PubMed ID: 3705262
[No Abstract] [Full Text] [Related]
17. Focal oxyntic gland atrophy with endocrine cell hyperplasia in Zollinger-Ellison syndrome during omeprazole treatment.
Caruana P; Azzoni C; Bertelé A; Annibale B; Franzé A; Delle Fave G; Bordi C
Histopathology; 1992 Oct; 21(4):359-63. PubMed ID: 1398539
[TBL] [Abstract][Full Text] [Related]
18. Management of patients with the Zollinger-Ellison syndrome.
Mocek FW; Richardson R; Williams R; Richardson JD
J Ky Med Assoc; 1993 Sep; 91(9):403-7. PubMed ID: 7901311
[TBL] [Abstract][Full Text] [Related]
19. Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome.
Bonfils S; Mignon M; Vallot ; Mayeur S
Scand J Gastroenterol Suppl; 1981 Jun; 69():119-23. PubMed ID: 6119775
[No Abstract] [Full Text] [Related]
20. Cushing's syndrome due to ectopic adrenocorticotropic hormone production by a non-metastatic gastrinoma after long-term conservative treatment of Zollinger-Ellison syndrome.
Raddatz D; Horstmann O; Basenau D; Becker H; Ramadori G
Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):636-40. PubMed ID: 10076790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
